United Services Automobile Association Biohaven Pharmaceutical Holding CO Ltd. Transaction History

United Services Automobile Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $246,745 - $326,551	-6,601 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$39.79 - $67.01 $47,230 - $79,540	1,187 Added 21.92%	6,601 $289,000
Q1 2019 May 13, 2019	BUY	$34.52 - $53.29 $186,891 - $288,512	5,414 New	5,414 $279,000
Q4 2018 Feb 13, 2019	SELL	$29.75 - $42.9 $483,140 - $696,696	-16,240 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$32.79 - $43.0 $5,902 - $7,740	-180 Reduced 1.1%	16,240 $610,000
Q2 2018 Aug 10, 2018	BUY	$23.62 - $42.29 $64,789 - $116,001	2,743 Added 20.06%	16,420 $649,000
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $307,595 - $472,677	13,677 New	13,677 $352,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.